Close Menu

marketing agreement

NEW YORK (GenomeWeb News) – Qiagen today announced a deal with Eli Lilly to develop a companion diagnostic for an investigational compound the drug manufacturer is developing for blood cancers.

NEW YORK (GenomeWeb News) – GE Healthcare's Clarient will commercialize Biocept's blood test for circulating tumor cells under a deal announced today.

NEW YORK (GenomeWeb News) – Alere has licensed the worldwide marketing rights to VitaPath Genetics' spina bifida risk assessment assay, the companies announced Wednesday.

Under the terms of the transaction, DiagnoCure will also advance the development of certain genomic tests for Signal Genetics.

The two companies will create HPLC columns prepacked with BAC's Capture Select affinity ligand specificities on Life Technologies' Poros chromatography media and HPLC columns.

CLG will sell the StemArray products and services to its current customers and other companies and research institutions.

Enzo plans to validate the test in house and then seek approval in New York State to market it as an LDT.

The database will be available to researchers at 55 medical centers and universities supported by the Clinical and Translational Sciences Award from the National Institutes of Health.

The company will use GSG Mess-und Analysnegerate for marketing and distribution in Germany, Austria, and Switzerland.

Topin will create a marketing strategy around OnDose, prepare marketing materials, and conduct meetings to educate oncologists about the pharmacokinetic test.

Pages

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.